Buyer guide
How Long Does Bioinformatics Analysis Take? Realistic Timelines by Service
How calendar turnaround varies by modality, deliverable depth, and whether you use a core, CRO, or in-house team.
Buyer guide
How calendar turnaround varies by modality, deliverable depth, and whether you use a core, CRO, or in-house team.
Three timelines affect most bioinformatics projects: pipeline compute and analyst hours, queue and contracting time, and iteration toward publication-ready deliverables. Build your schedule from the tables below, not from the fastest marketing claim.
| Category | Details | Source |
|---|---|---|
| Bulk RNA-seq analyst hours (standard pipeline) | 4 h (6 samples) to 12 h (25 samples), plus 1 h review meeting | [1] |
| Bulk RNA-seq calendar turnaround (standalone analysis, scoped) | Often ~4 weeks for custom analysis reports; focused packages can be shorter | [2] |
| End-to-end commercial RNA-seq project | Often ~2-4 weeks (project scope includes wet lab through data delivery) | [4] |
| scRNA-seq analyst hours | 8 h (6 samples) to 16 h (25 samples) | [1] |
| Multi-omics integration (~6 samples) | 3-6 months of analyst effort | [3] |
| Academic core queue lead time | Contact analysis core ≥3 months before anticipated data availability | [3] |
| In-house hire lag; core staffing pressure | 60-95 days to fill bioinformatics-related roles [5]; adequate staffing to keep up with analysis was the most pressing challenge among small cores [6] | G-Force Life Sciences, 2024; Dragon et al., 2020 |
Calendar turnaround depends on whether you need a primary pipeline report or a publication-ready package with figures, Methods text, and reproducible code. Analyst-hour estimates from academic rate cards reflect compute and standard review, not queue time, biological interpretation, or reviewer-response rounds.
| Analysis type | Primary pipeline (calendar) | Analyst hours (where published) | Publication-ready add-on |
|---|---|---|---|
| Bulk RNA-seq (6-15 samples) | ~4 weeks standalone analysis report [2]; ~2-4 weeks end-to-end RNA-seq project [4] | 4-10 h [1] | Additional weeks for figures, added contrasts, and Methods draft; confirm in SOW |
| scRNA-seq | Often several months at academic cores [3]; quote-based commercially | 8-16 h tiers [1] | Annotation and biological interpretation often dominate calendar time [7] |
| ATAC-seq | Several months for typical academic-core projects [3] | Quote-based | Integration with RNA-seq extends further |
| ChIP-seq | Quote-based at most cores | Quote-based | Often scoped with multi-omics projects |
| WGS / WES (research) | Weeks to months; scope-dependent | Quote-based | Variant interpretation and reporting drive the tail |
| Multi-omics integration (~6 samples) | 3-6 months [3] | Effort-intensive | Custom ML or pathway modelling adds time |
| Proteomics / metabolomics | ~3-4 weeks for standard core projects [8] | Included in core workflow | Larger projects may run longer [8] |
| Spatial transcriptomics | Quote-based | Limited published TAT | Plan explicitly in SOW |
Clinical pipelines have reported nine-day cancer WGS+transcriptome turnaround [9] and eleven workdays for routine clinical WGS [10]. Those timelines rely on dedicated infrastructure and are not a typical academic default. Proteomics cores often deliver preliminary data in about 3 weeks and reports in about 4 weeks [8].
Bioinformatics timelines usually span four phases, each with its own delay risk. Treating analysis as one step is a common reason a four-hour pipeline estimate turns into a four-month wait.
1. Pre-data: design, agreements, core booking, DMS planning. Pitt GAC advises contact at least 3 months before data [3]. Underpowered replicate counts can yield unreliable differential-expression results or force expanded analysis [11].
2. Data arrival: transfer, QC, failed-lane decisions. Define re-run policy before data arrives.
3. Active analysis: primary processing is often shortest; He et al. [7] report that biological interpretation and cluster annotation are often the most time-consuming scRNA-seq steps.
4. Post-delivery: feedback, added contrasts, figures, deposit, reviewer re-analysis. If the SOW ends at "standard pipeline," this phase usually needs added scope or a new PO.
Use this when scoping a grant, core request, or CRO statement of work:
Work backward from here.
Pitt GAC model.
Primary report vs. publication package with code.
Confirm both in the statement of work before signing.
Exclude, partial delivery, re-sequence recommendation.
Plan for weeks to months.
Unplanned reprocessing is common at peer review.
[12].
No single model is fastest for every project. Start dates vary by provider; in-house hires take 60-95 days to fill plus onboarding [5]; academic cores may have low analyst-hour estimates but longer calendar queues [6].
| Factor | Bioinformatics CRO | In-house hire | Academic core |
|---|---|---|---|
| Time to start after decision | Varies; confirm start date in SOW | 60-95 days to hire, plus onboarding | Weeks to months; book at least 3 months ahead [3] |
| Standard bulk RNA-seq | ~4 weeks standalone report [2] | Depends on individual bandwidth | Low analyst hours [1]; calendar wait often dominates |
| scRNA-seq / multi-omics | Quote-based; typically weeks to months | Fastest if dedicated specialist on staff | scRNA-seq: several months typical [3] |
| Rush / surge capacity | Ask whether rush is offered and what QA changes | Overtime or reprioritisation | Usually queue-limited |
| Iteration speed | Contract-defined review rounds | Fastest with dedicated FTE and clear priorities | Slowest when queue-bound between rounds |
| Continuity risk | Defined in SOW | Risk if employee leaves mid-project | Shared staff across labs; staffing pressure [6] |
Coriell's four-to-twelve-hour bulk RNA-seq tiers [1] are not "results in four hours."
Pitt GAC requires contact at least 3 months before data [3]; sequencing and analysis cores bill separately.
Splicing, pathway, and custom visualisation are additional effort [3].
Re-analysis contingency is not optional.
Many bundled pipelines lack adequate software-version or parameter documentation [13].
Define how long re-analysis stays included after delivery.
Work backward from your manuscript target: reviewer buffer (weeks to months, confirm with provider), figure/Methods iteration (scope-dependent), primary analysis, queue lead (0 to at least 3 months at busy cores; University of Pittsburgh GAC, n.d.), then sequencing and sample prep. Send these questions to two or three providers:
Often about 4 weeks for a standalone custom analysis report [2]; end-to-end RNA-seq projects at commercial providers may run about 2-4 weeks depending on scope [4]. Academic tiers list four to ten analyst hours for 6-15 samples [1], but queue wait can require booking at least 3 months ahead [3]. Publication figures and Methods add calendar time beyond primary differential-expression output, so confirm scope in the SOW.
Published academic tiers list eight to sixteen analyst hours [1], but Pitt GAC estimates several months for typical Cell Ranger/Seurat projects [3]. He et al. [7] report that biological interpretation and cluster annotation are often the most time-consuming steps in scRNA-seq, not primary processing alone. Commercial turnaround is quote-based, and publication-ready annotation validation adds time beyond pipeline output.
They measure different phases. Coriell hours cover pipeline execution plus one review meeting [1], not queue, transfer, interpretation, or figures. Explicyte targets custom analysis reports in about 4 weeks [2], and Discovery Life Sciences quotes about 2-4 weeks for end-to-end RNA-seq projects [4]. Ask which phase each number refers to.
For academic cores, book before sequencing. Pitt GAC requests contact at least 3 months before anticipated data availability [3], and advises contacting during the initial sequencing-core consultation so analysis can be queued. For CROs, engage when experimental design and deliverables are fixed, not when FASTQ files arrive. NIH grantees must submit a DMS Plan that specifies when and how scientific data will be shared, so budget analysis completion accordingly [12].
Research WGS/WES turnaround is scope-dependent. Weeks to months is a safer default when variant interpretation, cohort size, or integrative reporting are included. Clinical optimized workflows report a nine-day cancer WGS+transcriptome timeline [9] and eleven workdays for routine clinical WGS [10], but both rely on dedicated infrastructure rather than a typical academic core queue. Define variant interpretation, reporting format, and revision rounds in the SOW.
It is possible for a narrow primary pipeline on clean, queued data, but not usually for publication-ready delivery. Coriell's shortest tier is four analyst hours plus one review hour [1], assuming data are already in hand. Treat one-week promises for large cohorts or scRNA-seq cautiously unless the SOW lists exact deliverables.
Not always, but unscoped speed often skips documentation or review. Reproducibility failures are common [14], and many NGS papers lack adequate version or parameter documentation [13]. Faster delivery can work when scope is narrow and the SOW still requires pinned environments and parameter logs. Rush delivery without clear QA is a red flag.
Plan weeks to months per major reviewer round, and longer when editors request new contrasts, subgroup splits, or batch reprocessing. No published benchmark applies across journals; the timeline depends on scope and queue. Contract post-submission support up front, because many providers bill reviewer sprints separately. Primary-only SOWs usually make reviewer work a new purchase order with a separate timeline.
It is often one of the slower project types. Pitt GAC estimates three to six months of effort for about 6 samples integrating ATAC-seq, ChIP-seq, and RNA-seq [3], with cost roughly $5,000-$6,000 at that core. Dragon et al. [6] note rising demand for multi-omics integration at bioinformatics cores. Custom ML, harmonization across platforms, or publication figures can extend timelines, so confirm milestones in writing.
Only with a productive analyst and short queue. Hiring takes 60-95 days [5]; outsourced or core capacity may be faster until then. Onboarded in-house staff iterate quickest on familiar data. Cores can be faster when queues are short, and slower when staffing cannot keep up with demand [6].
Tell us:
We'll tell you:
Contact us to start with a free consultation. Need everyday bench calculators? Try our free lab tools.